What happened: Maruti Suzuki Q1 earnings fell, sales rose, and CBG projects were approved

Maruti Suzuki India reported an 11% year-on-year decline in Q1 net profit to ₹3,352 crore, compared with ₹3,758 crore in the same quarter of the previous year. The company attributed the profit decline largely to higher material costs.

Alongside weaker profit, the company reported stronger top-line performance and volume growth. Maruti Suzuki stated that net sales income increased 36% year-on-year to ₹49,959 crore. Management also reported sales volume growth of 29.3% year-on-year, with domestic growth split across segments: small cars up 34.1%, SUVs up 44.6%, and exports up 28.6%.

On market execution and inventory, Maruti Suzuki reported improved domestic market share of 41.2%, noting an increase of 2.3 percentage points. The company connected this improvement to the commissioning of its second plant at Kharkhoda and reported a quarter-end network inventory level of about 13 days.

In parallel with vehicle sales, Maruti Suzuki’s board approved four compressed biogas (CBG) projects in the first phase with a total budget of ₹561 crore. The company said it would consider expanding CBG manufacturing based on experience from these projects.

Background and earlier position: profit sensitivity to material costs and inventory-led operations